免费获得国外相关药品,最快 1 个工作日回馈药物信息

出境医 / 临床实验 / The International Survey of Acute Coronary Syndromes-ARCHIVES (ISACS ARCHIVES)

The International Survey of Acute Coronary Syndromes-ARCHIVES (ISACS ARCHIVES)

Study Description
Brief Summary:
ISACS ARCHIVES network is part of ISACS TC (NCT01218776) health care program. It is a collaborative network of research centers that support the rapid development of new scientific information and analytic tools. The ISACS ARCHIVES network assists health care providers, scientists, and policymakers seeking unbiased information about the outcomes, clinical effectiveness, safety, and appropriateness of health care items and services, particularly prescription medications and medical devices in acute coronary syndromes (ACS).

Condition or disease Intervention/treatment
Acute Coronary Syndrome Unstable Angina Pectoris Myocardial Infarction Coronary Disease Other: Non-interventional patient registry

Show Show detailed description
Study Design
Layout table for study information
Study Type : Observational
Estimated Enrollment : 130000 participants
Observational Model: Cohort
Time Perspective: Other
Official Title: The International Survey of Acute Coronary Syndromes- ARCHIVES
Actual Study Start Date : June 28, 2019
Estimated Primary Completion Date : June 28, 2022
Estimated Study Completion Date : June 28, 2022
Arms and Interventions
Group/Cohort Intervention/treatment
Male Other: Non-interventional patient registry
Non-interventional patient registry

Female Other: Non-interventional patient registry
Non-interventional patient registry

Kidney Disease Other: Non-interventional patient registry
Non-interventional patient registry

Diabetes Other: Non-interventional patient registry
Non-interventional patient registry

Elderly Other: Non-interventional patient registry
Non-interventional patient registry

Outcome Measures
Primary Outcome Measures :
  1. All causes death [ Time Frame: 30 days ]
    All causes death

  2. All causes death [ Time Frame: 6 months ]
    All causes death

  3. All causes death [ Time Frame: 1 year ]
    All causes death


Secondary Outcome Measures :
  1. Cardiovascular death [ Time Frame: up to 1 year ]
    Cardiovascular death

  2. Recurrent myocardial infarction [ Time Frame: up to 1 year ]
    A disorder characterized by signs and symptoms related to acute ischemia of the myocardium secondary to coronary artery disease

  3. Pharmacogenomics [ Time Frame: up to 1 year ]
    DNA sequence data to predict drug response and to inform drug discovery and development

  4. Cardiovascular genetics of coronary heart disease [ Time Frame: up to 1 year ]
    Common variant genotyping for risk prediction


Biospecimen Retention:   Samples With DNA
Databases with significant genomic data (e.g., genome-wide association studies, medical sequencing, molecular diagnostic assays), are expected to be deposited as well. Likewise, physical bio-samples can be included in the ISACS ARCHIVES.

Eligibility Criteria
Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Subjects admitted with a diagnosis of acute coronary syndromes
Criteria

Inclusion Criteria:

  • acute coronary syndromes

Exclusion Criteria:

  • under age or not able to give informed consent
Contacts and Locations

Contacts
Layout table for location contacts
Contact: Raffaele Bugiardini, MD +39 335 5612962 raffaele.bugiardini@unibo.it

Locations
Layout table for location information
Italy
University of Bologna Recruiting
Bologna, Italy, 40138
Contact: Raffaele Bugiardini, MD    +393355612962    raffaele.bugiardini@unibo.it   
Sponsors and Collaborators
University of Bologna
Tracking Information
First Submitted Date June 28, 2019
First Posted Date July 5, 2019
Last Update Posted Date September 7, 2020
Actual Study Start Date June 28, 2019
Estimated Primary Completion Date June 28, 2022   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures
 (submitted: July 1, 2019)
  • All causes death [ Time Frame: 30 days ]
    All causes death
  • All causes death [ Time Frame: 6 months ]
    All causes death
  • All causes death [ Time Frame: 1 year ]
    All causes death
Original Primary Outcome Measures Same as current
Change History
Current Secondary Outcome Measures
 (submitted: July 8, 2019)
  • Cardiovascular death [ Time Frame: up to 1 year ]
    Cardiovascular death
  • Recurrent myocardial infarction [ Time Frame: up to 1 year ]
    A disorder characterized by signs and symptoms related to acute ischemia of the myocardium secondary to coronary artery disease
  • Pharmacogenomics [ Time Frame: up to 1 year ]
    DNA sequence data to predict drug response and to inform drug discovery and development
  • Cardiovascular genetics of coronary heart disease [ Time Frame: up to 1 year ]
    Common variant genotyping for risk prediction
Original Secondary Outcome Measures
 (submitted: July 1, 2019)
  • Cardiovascular death [ Time Frame: up to 1 year ]
    Cardiovascular death
  • Recurrent myocardial infarction [ Time Frame: up to 1 year ]
    A disorder characterized by signs and symptoms related to acute ischemia of the myocardium secondary to coronary artery disease
  • Pharmacogenomics [ Time Frame: up to 1 year ]
    DNA sequence data to predict drug response and to inform drug discovery and development
  • Cardiovascular genetics of coronary heart disease [ Time Frame: up to 1 year ]
    Common variant genotyping for risk prediction
  • Adherence to internationally guideline recommended therapies across the participating countries [ Time Frame: up to 1 year ]
    Quality of adherence to guideline recommendations for life-saving treatment in heart disease
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title The International Survey of Acute Coronary Syndromes-ARCHIVES
Official Title The International Survey of Acute Coronary Syndromes- ARCHIVES
Brief Summary ISACS ARCHIVES network is part of ISACS TC (NCT01218776) health care program. It is a collaborative network of research centers that support the rapid development of new scientific information and analytic tools. The ISACS ARCHIVES network assists health care providers, scientists, and policymakers seeking unbiased information about the outcomes, clinical effectiveness, safety, and appropriateness of health care items and services, particularly prescription medications and medical devices in acute coronary syndromes (ACS).
Detailed Description

Purpose

ISACS-TC investigators may deposit to the ISACS ARCHIVES their registry data acquired prior to the first submitted date of ISACS-TC at ClinicalTrials.gov (October 7, 2010). Non- ISACS investigators with ACS data are welcome to deposit their data to the ISACS ARCHIVES as well. In this case the data may have been acquired prior or later than October 7, 2010. The data in the ISACS ARCHIVES will be catalogued and made available to the general research community. The ISACS ARCHIVES will use an established informatics infrastructure, hosted and managed by the ISACS TC (NCT01218776) and the Department of Electrical and Computer Engineering, University of California, Los Angeles, California, which will enable the sharing and use of data. The NIH. Gov. Registration number for the ISACS ARCHIVES will serve as the key for ACS related data submissions to the contact persons.

Applicable Data The ISACS ARCHIVES will accept only de-identified data from human subjects' studies on ACS (for a definition of human subjects see: https://humansubjects.nih.gov/glossary). This will include data from clinical trials, epidemiological surveys, and other types of studies involving human subjects. Databases with significant genomic data (e.g., genome-wide association studies, medical sequencing, molecular diagnostic assays), are expected to be deposited as well. Likewise, physical bio-samples can be included in the ISACS ARCHIVES.

Data Sharing Procedures Data submitted to the ISACS ARCHIVES must be de-identified by the investigator prior to submission. Submitted data will be subjected to algorithms that check for basic data accuracy. Any problematic data items will be summarized in a report and returned to the investigator for corrective action, if necessary, before data are accepted. Data will be made available for sharing with general research community 2 months after the deposit. This 2-month embargo period will provide study investigators with protected time to check for basic data accuracy. After the embargo, the data will be made available for sharing with the general research community. Investigators will be able to gain access to ISACS ARCHIVES data by submitting a data access request to ISACS TC (NCT01218776) contact persons. Data requests will be reviewed by an ISACS ARCHIVES Data Access Committee. The Department of Electrical and Computer Engineering, University of California, Los Angeles, California will collect data.

ISACS Data Archive Sharing The following is a summary of tasks and expectations related to submitting data to the ISACS ARCHIVES. The purpose of this summary is to provide an overview of data submission and data sharing via the ISACS ARCHIVES. This list only provides a summary of tasks.

Investigators are expected to:

  1. Collect Personally Identifiable Information (PII) from research subjects that will allow for the creation of the ISACS ARCHIVES Global Unique Identifier.
  2. Provide a de-identified subject ID, which is required for submission of data to the ISACS ARCHIVES.
  3. Complete and submit a Data-Sharing Agreement and Permission (DSAP) to ISACS TC (NCT01218776) contact persons.
  4. Review the ISACS TC data definition for the measures/experiments expected and define the project's data definition harmonized to that standard.
  5. Work with ISACS TC (NCT01218776) contact persons to define any undefined measures in accordance with ISACS TC practices.
  6. Specify the expected measures to be collected by the project in a summary table to be forwarded to the ISACS TC (NCT01218776) contact persons.
  7. Address any post submission quality assurance and quality control (QA/QC) checks that have been identified by the ISACS TC (NCT01218776).
  8. Create an ISACS ARCHIVES Library, linking a result from a publication, pipeline, or discovery of the data sent to ISACS ARCHIVES to its records for publications of results.

Policy Implementation ISACS ARCHIVES expects investigators and their institutions to provide basic plans for policy implementation

At present PI Study Investigators:

  • ISACS TC. International Survey of Acute Coronary Syndromes in Transitional Countries (ClinicalTrials.gov Identifier NCT01218776) from October 2010 to present. Contact person: Raffaele Bugiardini, MD University of Bologna email raffaele.bugiardini@unibo.it
  • HORACS: hospital registry for acute coronary syndrome in Serbia from January 2002 to September 2010. Contact person: Zorana Vasiljevic, MD Medical Faculty, University of Belgrade, email zoranav@eunet.rs
  • EMMACE-3 X. Long-term Follow-up of Health-Related Quality of Life in Patients With Acute Coronary Syndrome (ClinicalTrials.gov Identifier NCT01955525) during the period of 2011 to 2013. Contact person: Chris P Gale University of Leeds email c.p.gale@leeds.ac.uk

ISACS ARCHIVES Data Access Committee

  • Raffaele Bugiardini, University of Bologna (Principal Investigator)
  • Chris P Gale, University of Leeds
  • Olivia Manfrini, University of Bologna
  • Lina Badimon, Cardiovascular Research Institute (ICCC), CiberCV-Institute Carlos III, IIB-Sant Pau, Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona
  • Mihaela van der Schaar, University of Cambridge

ISACS ARCHIVES Data Sharing Coordinators

  • Edina Cenko University of Bologna
  • Jinsung Yoon, Department of Electrical and Computer Engineering, University of California, Los Angeles

Sponsor University of Bologna

Inquiries

Please direct all inquiries to:

Principal Investigator: Raffaele Bugiardini, MD University of Bologna

Study Type Observational
Study Design Observational Model: Cohort
Time Perspective: Other
Target Follow-Up Duration Not Provided
Biospecimen Retention:   Samples With DNA
Description:
Databases with significant genomic data (e.g., genome-wide association studies, medical sequencing, molecular diagnostic assays), are expected to be deposited as well. Likewise, physical bio-samples can be included in the ISACS ARCHIVES.
Sampling Method Probability Sample
Study Population Subjects admitted with a diagnosis of acute coronary syndromes
Condition
  • Acute Coronary Syndrome
  • Unstable Angina Pectoris
  • Myocardial Infarction
  • Coronary Disease
Intervention Other: Non-interventional patient registry
Non-interventional patient registry
Study Groups/Cohorts
  • Male
    Intervention: Other: Non-interventional patient registry
  • Female
    Intervention: Other: Non-interventional patient registry
  • Kidney Disease
    Intervention: Other: Non-interventional patient registry
  • Diabetes
    Intervention: Other: Non-interventional patient registry
  • Elderly
    Intervention: Other: Non-interventional patient registry
Publications * Bugiardini R, Yoon J, Kedev S, Stankovic G, Vasiljevic Z, Miličić D, Manfrini O, van der Schaar M, Gale CP, Badimon L, Cenko E. Prior Beta-Blocker Therapy for Hypertension and Sex-Based Differences in Heart Failure Among Patients With Incident Coronary Heart Disease. Hypertension. 2020 Sep;76(3):819-826. doi: 10.1161/HYPERTENSIONAHA.120.15323. Epub 2020 Jul 13.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status Recruiting
Estimated Enrollment
 (submitted: July 1, 2019)
130000
Original Estimated Enrollment Same as current
Estimated Study Completion Date June 28, 2022
Estimated Primary Completion Date June 28, 2022   (Final data collection date for primary outcome measure)
Eligibility Criteria

Inclusion Criteria:

  • acute coronary syndromes

Exclusion Criteria:

  • under age or not able to give informed consent
Sex/Gender
Sexes Eligible for Study: All
Ages 18 Years and older   (Adult, Older Adult)
Accepts Healthy Volunteers No
Contacts
Contact: Raffaele Bugiardini, MD +39 335 5612962 raffaele.bugiardini@unibo.it
Listed Location Countries Italy
Removed Location Countries  
 
Administrative Information
NCT Number NCT04008173
Other Study ID Numbers University of Bologna
Has Data Monitoring Committee Yes
U.S. FDA-regulated Product
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
IPD Sharing Statement
Plan to Share IPD: Yes
Responsible Party Raffaele Bugiardini, University of Bologna
Study Sponsor University of Bologna
Collaborators Not Provided
Investigators Not Provided
PRS Account University of Bologna
Verification Date September 2020